Q32 Bio Inc. seeks a Director of Program Management to lead Phase 3 development, registration support, and commercialization prep for alopecia areata and additional indications.
You will oversee the Program Team and sub-teams, aligning strategy, timelines, budgets, and risk across clinical development, regulatory, CMC, nonclinical, safety, and commercial functions. This hands-on leader will drive critical decisions, ensure information flow to executives and partners, and maintain program
#J-18808-LjbffrSenior Director, Program Management – Phase 3 Biotech in waltham at Unknown Company
This position is listed as full time and onsite.